PISETSKY MICHAEL A. 4
4 · SI-BONE, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
SI-BONE (SIBN) SVP Michael Pisetsky Receives RSUs, Sells Shares
What Happened
Michael A. Pisetsky, SVP, Operations & Administration and Chief Legal Officer of SI-BONE (SIBN), was granted restricted stock units (RSUs) on 2026-02-16 totaling 78,294 RSUs (58,720 + 9,787 + 9,787). On 2026-02-17 he sold 20,756 shares in multiple open-market trades at weighted-average prices of roughly $15.31–$15.41 per line, generating aggregate proceeds of approximately $318,643. The sales were to satisfy tax-withholding obligations in connection with RSU vesting (a "sell-to-cover"), not discretionary stock sales.
Key Details
- Transaction dates: RSU grants on 2026-02-16; sales on 2026-02-17; Form 4 filed 2026-02-18 (filed timely).
- Sales: 2,556 @ $15.39 ($39,336); 3,296 @ $15.41 ($50,806); 1,481 @ $15.32 ($22,688); 11,569 @ $15.34 ($177,428); 1,854 @ $15.31 ($28,385). Total proceeds ≈ $318,643.
- Trade price ranges: executed in multiple trades with reported price ranges approximately $15.13–$15.64 across the transactions (weighted averages shown on the Form).
- RSU vesting: One award vests over four years beginning Feb 15, 2026 with quarterly installments (time-based); other award(s) vest over three years subject to total shareholder return (TSR) performance vs. peers (performance-based).
- Tax withholding: The sales were made to cover tax-withholding on vested RSUs (footnote indicates "sell to cover"), not a discretionary sale.
- Holdings note: Form indicates 157,176 shares are issuable on settlement of RSUs (reported as includable in holdings).
- Timeliness: Filed within the Form 4 reporting window (not late).
Context
RSUs are awards that convert to shares if/when they vest; time-based RSUs vest on a schedule, performance RSUs vest only if performance goals are met. A "sell-to-cover" is common when insiders sell just enough shares at vesting to pay taxes and does not necessarily indicate a view on the company’s prospects.
Insider Transaction Report
Form 4
SI-BONE, Inc.SIBN
PISETSKY MICHAEL A.
SVP, Ops & Adm/Chief Legal Ofr
Transactions
- Award
Common Stock
[F1]2026-02-16+58,720→ 287,156 total - Award
Common Stock
[F2]2026-02-16+9,787→ 296,943 total - Award
Common Stock
[F2]2026-02-16+9,787→ 306,730 total - Sale
Common Stock
[F3][F4]2026-02-17$15.39/sh−2,556$39,336→ 304,174 total - Sale
Common Stock
[F3][F5]2026-02-17$15.41/sh−3,296$50,806→ 300,878 total - Sale
Common Stock
[F3][F6]2026-02-17$15.32/sh−1,481$22,688→ 299,397 total - Sale
Common Stock
[F3][F7]2026-02-17$15.34/sh−11,569$177,428→ 287,828 total - Sale
Common Stock
[F3][F6][F8]2026-02-17$15.31/sh−1,854$28,385→ 285,974 total
Footnotes (8)
- [F1]Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on February 15, 2026, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date.
- [F2]Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant.
- [F3]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F4]This transaction was executed in multiple trades at prices ranging from $15.24 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]This transaction was executed in multiple trades at prices ranging from $15.25 USD to $15.64 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.51 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.64 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]Includes 157,176 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Signature
/s/ Michael A. Pisetsky|2026-02-18